rs541497967
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PM4_SupportingBP6BS2
The NM_000384.3(APOB):c.6639_6641delTGA(p.Asp2213del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00409 in 1,561,718 control chromosomes in the GnomAD database, including 42 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000384.3 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00416 AC: 633AN: 152144Hom.: 2 Cov.: 33
GnomAD3 exomes AF: 0.00490 AC: 1069AN: 217994Hom.: 5 AF XY: 0.00508 AC XY: 601AN XY: 118418
GnomAD4 exome AF: 0.00408 AC: 5752AN: 1409456Hom.: 40 AF XY: 0.00401 AC XY: 2795AN XY: 696196
GnomAD4 genome AF: 0.00416 AC: 633AN: 152262Hom.: 2 Cov.: 33 AF XY: 0.00442 AC XY: 329AN XY: 74446
ClinVar
Submissions by phenotype
Hypercholesterolemia, familial, 1 Uncertain:4Benign:3
- -
1/96 normolipidaemic Portuguese controls -
- -
- -
- -
- -
- -
not provided Benign:4
- -
APOB: PM4:Supporting, BS2 -
This variant is associated with the following publications: (PMID: 27153395, 9050776, 24234650, 23680767, 33111339) -
- -
not specified Benign:2
Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: ExAC: 1.9% (122/6498) Finnish chromosomes -
- -
Familial hypercholesterolemia Benign:2
- -
- -
Hypercholesterolemia, autosomal dominant, type B;C4551990:Familial hypobetalipoproteinemia 1 Benign:1
- -
Hypercholesterolemia, autosomal dominant, type B Benign:1
- -
APOB-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Cardiovascular phenotype Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at